ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.550
+0.040 (2.65%)
Jul 3, 2026, 4:15 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 5.47 million as of July 2, 2026. Its market cap has decreased by -90.20% in one year.
Market Cap
5.47M
Enterprise Value
-15.13M
Revenue
16.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 5.47M, a decrease of -95.35%. That is a compound annual growth rate of -26.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 5.47M | -90.25% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 83.17M |
| Alzinova AB | 81.82M |
| 2cureX AB | 71.78M |
| Pila Pharma AB | 56.65M |
| Modus Therapeutics Holding AB | 45.73M |
| Fluicell AB | 42.45M |
| Guard Therapeutics International AB | 32.27M |
| Magle Chemoswed Holding AB | 29.32M |